Kubota; Katsumi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kubota; Katsumi.The latest application filed is for "3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of".

Company Profile

2.4.8

Kubota; Katsumi - Osaka-shi JP
Kubota; Katsumi - Osaka JP
Kubota; Katsumi - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-(aryl Or Heteroaryl) Methyleneindolin-2-one Derivatives As Inhibitors Of Cancer Stem Cell Pathway Kinases For The Treatment Of App 20190241569 - Li; Chiang Jia ; et al.	2019-08-08
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative App 20190241550 - Tsuboi; Katsunori ; et al.	2019-08-08
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative App 20160075697 - Tsuboi; Katsunori ; et al.	2016-03-17
3-(aryl Or Heteroaryl) Methyleneindolin-2-one Derivatives As Inhibitors Of Cancer Stem Cell Pathway Kinases For The Treatment Of Cancer App 20160031888 - Li; Chiang Jia ; et al.	2016-02-04
Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative Grant 9,227,962 - Tsuboi , et al. January 5, 2	2016-01-05
Uracil derivative and use thereof for medical purposes Grant 9,040,516 - Shiro , et al. May 26, 2	2015-05-26
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative App 20140275076 - Tsuboi; Katsunori ; et al.	2014-09-18
Uracil Derivative And Use Thereof For Medical Purposes App 20140179670 - Shiro; Tomoya ; et al.	2014-06-26
.beta.-lactam compounds and process for producing the same Grant 7,163,936 - Sunagawa , et al. January 16, 2	2007-01-16
Novel beta-lactam compounds and process for producing the same App 20040102433 - Sunagawa, Makoto ; et al.	2004-05-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.